Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05881460 · ClinicalTrials.gov registry record · NA

Vibrotactile Coordinated Reset: a Non-invasive Treatment for Parkinson's Disease 2

A NA study of Parkinson Disease, sponsored by Synergic Medical Technologies.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05881460 is a NA study of Parkinson Disease that is actively recruiting participants, run by Synergic Medical Technologies. The registered enrollment target is 30 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05881460, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Synergic Medical Technologies.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor function in people with Parkinson's disease (PD). vCR will be administered with a device called the Vibrotactile (VT) Touch device. vCR can be used in conjunction with medication and is expected to delay the need to increase dopamine medication. It also provides a more flexible alternative to deep brain stimulation (DBS) in that the vCR therapy can be easily stopped or modified to better suit the patients' needs.

Conditions Studied

Interventions

  • DEVICE Active vibrotactile coordinated reset
  • DEVICE Sham vibrotactile coordinated reset

Study Locations (1)

Oregon

  • Oregon Health & Science Institution - Portland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-07-12
Est. Completion 2026-01
Phase NA

Sponsor

Synergic Medical Technologies

3 total trials

What the Registry Record Tells You About NCT05881460

The ClinicalTrials.gov registry entry for NCT05881460 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Synergic Medical Technologies, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Active vibrotactile coordinated reset is the first listed.

NCT05881460 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05881460 about?

NCT05881460 is a clinical study titled "Vibrotactile Coordinated Reset: a Non-invasive Treatment for Parkinson's Disease 2". The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor function in people with Parkinson's disease (PD). vCR will be administered with a device called the Vibrotactile (VT) Touch device. vCR can be used in conjunction with medication and is ...

What is the current status of trial NCT05881460?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-12. Estimated completion is 2026-01.

What conditions does trial NCT05881460 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05881460?

The interventions under investigation include: Active vibrotactile coordinated reset (DEVICE), Sham vibrotactile coordinated reset (DEVICE).

Who is sponsoring clinical trial NCT05881460?

This trial is sponsored by Synergic Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05881460 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.